In this retrospective study, we carried out a characterization of the mutations in exon 2 of the KRAS and NRAS genes in a selected sample of Venezuelan patients with CRC through the SNaPshot method and compared the results with the Sanger sequencing technique. This evidence concerns the gene NRAS and colorectal carcinoma.